| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |